CT52923
CT52923 is a potent, orally bioavailable, and ATP-competitive PDGFR antagonist. It is widely used in preclinical research to investigate diseases driven by PDGFR signaling, including cancer, fibrosis, and atherosclerosis, in both cellular and animal models.
Product Specifications
CAS Number
205256-55-9
Product Name Alternative
CT52923, CT-52923, CT 52923, PDGFR
Field of Research
Cardiovascular Research, Signal Transduction
Purity
99.88% (May vary between batches)
Solubility
DMSO:60 mg/mL (128.33 mM) ;10% DMSO+90% Corn Oil:2.5 mg/mL (5.35 mM)
Smiles
COc1cc2ncnc (N3CCN (CC3) C (=S) NCc3ccc4OCOc4c3) c2cc1OC
Molecular Formula
C23H25N5O4S
Molecular Weight
467.54
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1365797-01 0.02 mg (E-Coli)
Recombinant Neorickettsia sennetsu Peptide chain release factor 2 (prfB)
Sign In for Pricing
View Details